Israeli drug company Kamada reports that on recent clinical trials done with its Glassia drug, results have shown positive results for treating lung disease. Laboratory mice with bacterial lung infection have shown significant improvement once treated with the drug.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments